Skip to main content
Erschienen in: Virchows Archiv 5/2010

01.11.2010 | Original Article

Murine immune response induced by Leishmania major during the implantation of paraffin tablets

verfasst von: Maria Letícia Costa Reis, Vanessa Martins Ferreira, Xia Zhang, Ricardo Gonçalves, Leda Quércia Vieira, Washington Luiz Tafuri, David M. Mosser, Wagner Luiz Tafuri

Erschienen in: Virchows Archiv | Ausgabe 5/2010

Einloggen, um Zugang zu erhalten

Abstract

We carried out a model of chronic inflammation using a subcutaneous paraffin tablet in mice experimentally infected with Leishmania major. It was previously reported that the parasite load following paraffin implantation occurred at a peak of 21 days in both BALB/c and C57BL/6 mice. At the present study, we have investigated what cytokines and chemokines are directly related to the parasite load in C57BL/6 mice. All mice were divided in four groups: mice implanted with paraffin tablets; mice experimentally infected with L. major; mice implanted with paraffin tablets and experimentally infected with L. major; and mice submitted only to the surgery were used for the Real-Time Polymerase Chain Reaction (RT-PCR) controls. Fragments of skin tissue and the tissue surrounding the paraffin tablets (inflammatory capsule) were collected for histopathology and RT-PCR studies. By 21 days, a diffuse chronic inflammatory reaction was mainly observed in the deep dermis where macrophages parasitized with Leishmania amastigotes were also found. RT-PCR analysis has shown that BALB/c mice showed strong IL-4 and IL-10 mRNA expression than controls with very little expression of IFN-γ. In contrast, both IFN-γ and IL-10 mRNA was found in higher levels in C57BL/6 animals. Moreover, in C57BL/6 mice the expression of chemokines mRNA of CCL3/MIP-1α was more highly expressed than CCL2/MCP-1. We conclude that the Th1 immune response C57BL/6 did not change to a Th2 response, even though C57BL/6 animals presented higher parasitism than BALB/c mice 21 days after infection and paraffin implantation.
Literatur
3.
Zurück zum Zitat Diefenbach A, Schindler H, Donhauser N, Lorenz E, Laskay T, MacMicking J, Rollinghoff M, Gresser I, Bogdan C (1998) Type 1 interferon (IFNalpha/beta) and type 2 nitric oxide synthase regulate the innate immune response to a protozoan parasite. Immunity 8:77–87. doi:10.1016/S1074-7613(00)80460-4 CrossRefPubMed Diefenbach A, Schindler H, Donhauser N, Lorenz E, Laskay T, MacMicking J, Rollinghoff M, Gresser I, Bogdan C (1998) Type 1 interferon (IFNalpha/beta) and type 2 nitric oxide synthase regulate the innate immune response to a protozoan parasite. Immunity 8:77–87. doi:10.​1016/​S1074-7613(00)80460-4 CrossRefPubMed
5.
Zurück zum Zitat Vester B, Muller K, Solbach W, Laskay T (1999) Early gene expression of NK cell-activating chemokines in mice resistant to Leishmania major. Infect Immun 67:3155–3159PubMed Vester B, Muller K, Solbach W, Laskay T (1999) Early gene expression of NK cell-activating chemokines in mice resistant to Leishmania major. Infect Immun 67:3155–3159PubMed
7.
Zurück zum Zitat Von Stebut E, Belkaid Y, Jakob T, Sacks DL, Udey MC (1998) Uptake of Leishmania major amastigotes results in activation and interleukin 12 release from murine skin-derived dendritic cells: implications for the initiation of anti-Leishmania immunity. J Exp Med 188:1547–1552CrossRef Von Stebut E, Belkaid Y, Jakob T, Sacks DL, Udey MC (1998) Uptake of Leishmania major amastigotes results in activation and interleukin 12 release from murine skin-derived dendritic cells: implications for the initiation of anti-Leishmania immunity. J Exp Med 188:1547–1552CrossRef
8.
Zurück zum Zitat Liew FY, Li Y, Millott S (1990) Tumor necrosis factor-alpha synergizes with IFN-gamma in mediating killing of Leishmania major through the induction of nitric oxide. J Immunol 145:4306–4310PubMed Liew FY, Li Y, Millott S (1990) Tumor necrosis factor-alpha synergizes with IFN-gamma in mediating killing of Leishmania major through the induction of nitric oxide. J Immunol 145:4306–4310PubMed
9.
Zurück zum Zitat Ritter U, Korner H (2002) Divergent expression of inflammatory dermal chemokines in cutaneous leishmaniasis. Parasite Immunol 24:295–301CrossRefPubMed Ritter U, Korner H (2002) Divergent expression of inflammatory dermal chemokines in cutaneous leishmaniasis. Parasite Immunol 24:295–301CrossRefPubMed
11.
Zurück zum Zitat Silveira FT, Lainson R, Corbett CE (2005) Further observations on clinical, histopathological, and immunological features of borderline disseminated cutaneous leishmaniasis caused by Leishmania (Leishmania) amazonensis. Mem Inst Oswaldo Cruz 100:525–534CrossRefPubMed Silveira FT, Lainson R, Corbett CE (2005) Further observations on clinical, histopathological, and immunological features of borderline disseminated cutaneous leishmaniasis caused by Leishmania (Leishmania) amazonensis. Mem Inst Oswaldo Cruz 100:525–534CrossRefPubMed
12.
Zurück zum Zitat Sousa AQ, Pompeu MML, Sólon FRN, Frutuoso MS, Teixeira MJ, Silva TMJ (2006) Disseminated cutaneous leishmaniasis: a patient with 749 lesions. Braz J Infect Dis 10:230–230PubMed Sousa AQ, Pompeu MML, Sólon FRN, Frutuoso MS, Teixeira MJ, Silva TMJ (2006) Disseminated cutaneous leishmaniasis: a patient with 749 lesions. Braz J Infect Dis 10:230–230PubMed
13.
Zurück zum Zitat Roychoudhury K, Roy S (2004) Role of chemokines in Leishmania infection. Curr Mol Med 4:691–696CrossRefPubMed Roychoudhury K, Roy S (2004) Role of chemokines in Leishmania infection. Curr Mol Med 4:691–696CrossRefPubMed
14.
Zurück zum Zitat Zlotnik A, Yoshie O, Nomiyama H (2006) The chemokine and chemokine receptor superfamilies and their molecular evolution. Genome Biol 7:243.1–243.10. doi: 10.1186/gb-2006-7-12-243 Zlotnik A, Yoshie O, Nomiyama H (2006) The chemokine and chemokine receptor superfamilies and their molecular evolution. Genome Biol 7:243.1–243.10. doi: 10.​1186/​gb-2006-7-12-243
15.
Zurück zum Zitat Scott P (1991) IFN-gamma modulates the early development of Th1 and Th2 responses in a murine model of cutaneous leishmaniasis. J Immunol 147:3149–3155PubMed Scott P (1991) IFN-gamma modulates the early development of Th1 and Th2 responses in a murine model of cutaneous leishmaniasis. J Immunol 147:3149–3155PubMed
18.
Zurück zum Zitat Tafuri WL, Melo MN, Paiva MC, Mosser DM, Tafuri WL (2000) Kinetics of an experimental inflammatory reaction induced by Leishmania major during the implantation of paraffin tablets in mice. Virchows Arch 437:429–435. doi:10.1007/s004280000231 CrossRefPubMed Tafuri WL, Melo MN, Paiva MC, Mosser DM, Tafuri WL (2000) Kinetics of an experimental inflammatory reaction induced by Leishmania major during the implantation of paraffin tablets in mice. Virchows Arch 437:429–435. doi:10.​1007/​s004280000231 CrossRefPubMed
20.
Zurück zum Zitat Vieira LQ, Goldschmidt M, Nashleanas M, Pfeffer K, Mak T, Scott P (1996) Mice lacking the TNF receptor p55 fail to resolve lesions caused by infection with Leishmania major, but control parasite replication. J Immunol 157:827–835PubMed Vieira LQ, Goldschmidt M, Nashleanas M, Pfeffer K, Mak T, Scott P (1996) Mice lacking the TNF receptor p55 fail to resolve lesions caused by infection with Leishmania major, but control parasite replication. J Immunol 157:827–835PubMed
22.
Zurück zum Zitat Yang Z, Mosser DM, Zhang X (2007) Activation of the MAPK, ERK, following Leishmania amazonensis infection of macrophages. J Immunol 178:1077–1085PubMed Yang Z, Mosser DM, Zhang X (2007) Activation of the MAPK, ERK, following Leishmania amazonensis infection of macrophages. J Immunol 178:1077–1085PubMed
24.
Zurück zum Zitat Kane MM, Mosser MD (2001) The role of IL-10 in promoting disease progression in leishmaniasis. J Immunol 166:1141–1147PubMed Kane MM, Mosser MD (2001) The role of IL-10 in promoting disease progression in leishmaniasis. J Immunol 166:1141–1147PubMed
25.
Zurück zum Zitat Anderson CF, Oukka M, Kuchroo VJ, Sacks D (2007) CD4(+)CD25(-)Foxp3(-) Th1 cells are the source of IL-10-mediated immune suppression in chronic cutaneous leishmaniasis. J Exp Med 204:285–297. doi:10.1084/jem.20061886 CrossRefPubMed Anderson CF, Oukka M, Kuchroo VJ, Sacks D (2007) CD4(+)CD25(-)Foxp3(-) Th1 cells are the source of IL-10-mediated immune suppression in chronic cutaneous leishmaniasis. J Exp Med 204:285–297. doi:10.​1084/​jem.​20061886 CrossRefPubMed
26.
Zurück zum Zitat Anderson CF, Mendez S, Sacks DL (2005) Nonhealing infection despite Th1 polarization produced by a strain of Leishmania major in C57BL/6 mice. J Immunol 174:2934–2941PubMed Anderson CF, Mendez S, Sacks DL (2005) Nonhealing infection despite Th1 polarization produced by a strain of Leishmania major in C57BL/6 mice. J Immunol 174:2934–2941PubMed
27.
Zurück zum Zitat Scharton-Kersten T, Scott P (1995) The role of the innate immune response in Th1 cell development following Leishmania major infection. J Leukoc Biol 57:515–522PubMed Scharton-Kersten T, Scott P (1995) The role of the innate immune response in Th1 cell development following Leishmania major infection. J Leukoc Biol 57:515–522PubMed
28.
Zurück zum Zitat Matte C, Olivier M (2002) Leishmania-induced cellular recruitment during the early inflammatory response: modulation of proinflammatory mediators. J Infect Dis 185:673–681CrossRefPubMed Matte C, Olivier M (2002) Leishmania-induced cellular recruitment during the early inflammatory response: modulation of proinflammatory mediators. J Infect Dis 185:673–681CrossRefPubMed
29.
Zurück zum Zitat Barbi J, Ogumu S, Rosas LE, Carlson T, Lu B, Gerard C, Lezama-Davila CM, Satoskar AR (2007) Lack of CXCR3 delays the development of hepatic inflammation but does not impair resistance to Leishmania donovani. J Infect Dis 195:1713–1717CrossRefPubMed Barbi J, Ogumu S, Rosas LE, Carlson T, Lu B, Gerard C, Lezama-Davila CM, Satoskar AR (2007) Lack of CXCR3 delays the development of hepatic inflammation but does not impair resistance to Leishmania donovani. J Infect Dis 195:1713–1717CrossRefPubMed
30.
Zurück zum Zitat Daly C, Rollins BJ (2003) Monocyte chemoattractant protein-1 (CCL2) in inflammatory disease and adaptive immunity: therapeutic opportunities and controversies. Microcirculation 10:247–257PubMed Daly C, Rollins BJ (2003) Monocyte chemoattractant protein-1 (CCL2) in inflammatory disease and adaptive immunity: therapeutic opportunities and controversies. Microcirculation 10:247–257PubMed
32.
Zurück zum Zitat Aliberti J, Reis e Sousa C, Schito M, Hieny S, Wells T, Huffnagle GB, Sher A (2000) CCR5 provides a signal for microbial induced production of IL-12 by CD8 alpha + dendritic cells. Nat Immunol 1:83–87CrossRefPubMed Aliberti J, Reis e Sousa C, Schito M, Hieny S, Wells T, Huffnagle GB, Sher A (2000) CCR5 provides a signal for microbial induced production of IL-12 by CD8 alpha + dendritic cells. Nat Immunol 1:83–87CrossRefPubMed
33.
Zurück zum Zitat Santiago HC, Oliveira CF, Santiago L, Ferraz FO, de Souza DG, de-Freitas LA, Afonso LC, Teixeira MM, Gazzinelli RT, Vieira LQ (2004) Involvement of the chemokine RANTES (CCL5) in resistance to experimental infection with Leishmania major. Infect Immun 72:4918–4923. doi:10.1128/IAI.72.8.4918-4923.2004 CrossRefPubMed Santiago HC, Oliveira CF, Santiago L, Ferraz FO, de Souza DG, de-Freitas LA, Afonso LC, Teixeira MM, Gazzinelli RT, Vieira LQ (2004) Involvement of the chemokine RANTES (CCL5) in resistance to experimental infection with Leishmania major. Infect Immun 72:4918–4923. doi:10.​1128/​IAI.​72.​8.​4918-4923.​2004 CrossRefPubMed
34.
Zurück zum Zitat Murdoch C, Finn A (2000) Chemokine receptors and their role in inflammation and infectious diseases. Blood 95:3032–3043PubMed Murdoch C, Finn A (2000) Chemokine receptors and their role in inflammation and infectious diseases. Blood 95:3032–3043PubMed
35.
Zurück zum Zitat Sato N, Ahuja SK, Quinones M, Kostecki V, Reddick RL, Melby PC, Kuziel WA, Ahuja SS (2000) CC chemokine receptor (CCR)2 is required for langerhans cell migration and localization of T helper cell type 1 (Th1)-inducing dendritic cells. Absence of CCR2 shifts the Leishmania major-resistant phenotype to a susceptible state dominated by Th2 cytokines, b cell outgrowth, and sustained neutrophilic inflammation. J Exp Med 192:205–218CrossRefPubMed Sato N, Ahuja SK, Quinones M, Kostecki V, Reddick RL, Melby PC, Kuziel WA, Ahuja SS (2000) CC chemokine receptor (CCR)2 is required for langerhans cell migration and localization of T helper cell type 1 (Th1)-inducing dendritic cells. Absence of CCR2 shifts the Leishmania major-resistant phenotype to a susceptible state dominated by Th2 cytokines, b cell outgrowth, and sustained neutrophilic inflammation. J Exp Med 192:205–218CrossRefPubMed
36.
Zurück zum Zitat Conrad SM, Strauss-Ayali D, Field AE, Mack M, Mosser DM (2007) Leishmania-derived murine monocyte chemoattractant protein 1 enhances the recruitment of a restrictive population of CC chemokine receptor 2-positive macrophages. Infect Immun 75:653–665. doi:10.1128/IAI.01314-06 CrossRefPubMed Conrad SM, Strauss-Ayali D, Field AE, Mack M, Mosser DM (2007) Leishmania-derived murine monocyte chemoattractant protein 1 enhances the recruitment of a restrictive population of CC chemokine receptor 2-positive macrophages. Infect Immun 75:653–665. doi:10.​1128/​IAI.​01314-06 CrossRefPubMed
38.
Zurück zum Zitat Brandonisio O, Panaro MA, Fumarola I, Sisto M, Leogrande D, Acquafredda A, Spinelli D, Mitolo V (2002) Macrophage chemotactic protein-1 and macrophage inflammatory protein-1 alpha induce nitric oxide release and enhance parasite killing in Leishmania infantum-infected human macrophages. Clin Exp Med 2:125–129. doi:10.1007/s102380200017 CrossRefPubMed Brandonisio O, Panaro MA, Fumarola I, Sisto M, Leogrande D, Acquafredda A, Spinelli D, Mitolo V (2002) Macrophage chemotactic protein-1 and macrophage inflammatory protein-1 alpha induce nitric oxide release and enhance parasite killing in Leishmania infantum-infected human macrophages. Clin Exp Med 2:125–129. doi:10.​1007/​s102380200017 CrossRefPubMed
Metadaten
Titel
Murine immune response induced by Leishmania major during the implantation of paraffin tablets
verfasst von
Maria Letícia Costa Reis
Vanessa Martins Ferreira
Xia Zhang
Ricardo Gonçalves
Leda Quércia Vieira
Washington Luiz Tafuri
David M. Mosser
Wagner Luiz Tafuri
Publikationsdatum
01.11.2010
Verlag
Springer-Verlag
Erschienen in
Virchows Archiv / Ausgabe 5/2010
Print ISSN: 0945-6317
Elektronische ISSN: 1432-2307
DOI
https://doi.org/10.1007/s00428-010-0974-9

Weitere Artikel der Ausgabe 5/2010

Virchows Archiv 5/2010 Zur Ausgabe

Neu im Fachgebiet Pathologie

Molekularpathologische Untersuchungen im Wandel der Zeit

Open Access Biomarker Leitthema

Um auch an kleinen Gewebeproben zuverlässige und reproduzierbare Ergebnisse zu gewährleisten ist eine strenge Qualitätskontrolle in jedem Schritt des Arbeitsablaufs erforderlich. Eine nicht ordnungsgemäße Prüfung oder Behandlung des …

Vergleichende Pathologie in der onkologischen Forschung

Pathologie Leitthema

Die vergleichende experimentelle Pathologie („comparative experimental pathology“) ist ein Fachbereich an der Schnittstelle von Human- und Veterinärmedizin. Sie widmet sich der vergleichenden Erforschung von Gemeinsamkeiten und Unterschieden von …

Gastrointestinale Stromatumoren

Open Access GIST CME-Artikel

Gastrointestinale Stromatumoren (GIST) stellen seit über 20 Jahren ein Paradigma für die zielgerichtete Therapie mit Tyrosinkinaseinhibitoren dar. Eine elementare Voraussetzung für eine mögliche neoadjuvante oder adjuvante Behandlung bei …

Personalisierte Medizin in der Onkologie

Aufgrund des erheblichen technologischen Fortschritts in der molekularen und genetischen Diagnostik sowie zunehmender Erkenntnisse über die molekulare Pathogenese von Krankheiten hat in den letzten zwei Jahrzehnten ein grundlegender …